Tuesday, September 28, 2021

Enzene gets DCGI nod for biosimilar drug to treat haematological disorder

Tuesday, September 14, 2021, 21:03
This news item was posted in Lifestyle category and has 0 Comments so far.
The symptoms of this disorder ranges from mild skin bleeding and bruises to potentially fatal internal bleeding, such as in the gastrointestinal tract and the brain.

Powered by WPeMatico

Both comments and pings are currently closed.

Comments are closed for this story.